Search Results 191-200 of 11350 for Antifungal Resistance
... resistance as compared to placebo in subjects with pulmonary hypertension after left ventricular assist device (LVAD) implantation. Participation eligibility.
Known diagnosis of allergic bronchopulmonary aspergillosis or invasive fungal disease. ... Prior use of systemic antifungals within the past 3 months. Note: Other ...
... resistance. Submission of < 15 unstained slides is permitted, and patients ... Active infection requiring systemic antibacterial, antifungal, or ...
A new gene that makes bacteria highly resistant to a last-resort class of antibiotics has been identified in China, and doctors are warning of the global ...
... fungal-free survival at Day 90 (±7 days). The primary objective of the European Medicines Agency (EMA) for this study is to demonstrate superiority in ...
Antifungal prophylaxis in lung transplant: A survey of United States' transplant centers. ... Comparison of different treatments for isoniazid-resistant ...
Miconazole buccal treats fungus (yeast) infections in the mouth and throat (oral thrush). It belongs to the group of medicines called antifungals and works by ...
Antimicrobial Awareness Week, Nov. 18–24, serves as a global call to action to address antimicrobial resistance (AMR) — a growing public health concern that ...
Isavuconazonium is used to treat serious fungal or yeast infections, including invasive aspergillosis and invasive mucormycosis. This medicine works by ...
D. February 23, 2026. Mayo Clinic study identifies mechanism behind immunotherapy resistance in lung cancer featured image.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.